Manager TitleAgeSince
Chief Executive Officer - 01/04/2026
Chief Tech/Sci/R&D Officer - 17/07/2009
Director of Finance/CFO 60 01/07/2022
Director TitleAgeSince
Director/Board Member 58 09/07/2020
Chairman 68 09/12/2021
Director/Board Member 78 01/09/2004
Date Insider Type Main position Quantity % Market Cap. Importance
7/9/20 A Tender

Chief Executive Officer

29,206 0.1196%
7/9/20 A Tender

Chief Financial Officer

500 0.0020% -
7/9/20 A Tender

Director

102,200 0.4187%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+2.84% - - 1.41M
+1.54%+2.16%-15.02%+13.91% 181B
-5.69%-4.60%-20.58%+11.60% 120B
-0.54%+1.21%+6.14%+38.00% 119B
+3.42%+1.71%-42.32%+9.52% 91.44B
+0.49%+0.80%-2.22%+79.95% 63.07B
-0.46%-0.64%+9.87%+80.82% 55.8B
-0.54%-0.69%+10.12%-21.33% 54.03B
-3.20%+0.08%-10.77%+41.48% 45.38B
+0.58%+2.00%-1.07%-6.43% 34.37B
Average -0.46%+0.48%-7.32%+27.50% 84.83B
Weighted average by Cap. -0.42%+0.76%-10.33%+25.35%
Logo TearLab Corporation
TearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company, through its subsidiary TearLab Research, Inc., develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care. Its product, the TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor's office. The TearLab Osmolarity System consists of approximately three components: the TearLab disposable, the TearLab Pen, and the TearLab Reader. The TearLab disposable is a single-use microfluidic microchip. The TearLab Pen is a hand-held device that interfaces with the TearLab disposable. The TearLab Reader is a small desktop unit that allows for the docking of the TearLab Pen.
Employees
-